Companies Dominating the Neurostimulation Devices Landscape
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Boston Scientific Corporation
- Integer Holdings Corporation
- Medtronic
- Nevro Corp.
- NeuroSigma, Inc.
- NeuroPace, Inc.
- Neuronetics
- Synapse Biomedical Inc.
- Soterix Medical, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Neurostimulation Devices Market in 2025 is assessed at USD 12.43 billion.
The global market size was valued at over USD 11.32 billion in 2024 and is expected to expand at a CAGR of around 12.3%, surpassing USD 51.14 billion revenue by 2037.
North America is set to secure largest share by 2037, driven by increasing prevalence of neurological disorders and the growing geriatric population.
The major players in the market include Abbott Laboratories, Boston Scientific Corporation, Integer Holdings Corporation, Medtronic, Nevro Corp., NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Synapse Biomedical Inc., Soterix Medical, Inc.
